Broker recommendations for Medtronic Plc
The Medtronic Plc stock is rated at 1.288462 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Friday 3 July, 2020 by a total of 26 brokers. This means that the consensus of the 26 different brokers is leaning toward to buy/moderate buy.
1 (3.85%) Underweight
0 (0%) Hold
5 (19.23%) Overweight
1 (3.85%) Buy
Price target by analysts
The 23 latest analyst estimates, per Saturday 8 August, 2020, show the following high, low and average price targets.
Target Average: 111.09 USD
Target High: 130 USD
Target Low: 90 USD
10 healthcare startups that could be M&A targets after Teladoc’s record-breaking $18.5 billion deal for Livongo
Thursday, 13 August 2020, 17:53:53
On August 5, telehealth giant Teladoc struck an $18.5 billion deal to buy Livongo , a chronic-care company. The record deal is sending shockwaves through an industry that analysts say is ripe for more mergers and acquisitions. Business Insider asked 10 venture capitalists and analysts about the impending consolidation in digital health. They listed 10 startups in mental health, drug research, telehealth, and more that are likely to be acquired or make deals of their own soon. For more stories like this, sign up here for our healthcare newsletter, Dispensed . On August 5, telehealth giant Teladoc struck an $18.5 billion deal to buy Livongo , a chronic-care company. It’s the biggest deal in digital health history, and it’s sending shockwaves through an industry that’s ripe for more mergers and acquisitions, according to Rock Health, a digital health venture fund and advisory firm. “This announcement is merely the starter’s pistol for an inevitable virtual care platforms race,” wrote Sari Kaganoff, a general manager at Rock Health, in a report on August 6 .
— Business Insider
Global Spinal Fusion Market 2015-2030: Key Trends, Regional & Competitive Insights, COVID-19 Impact – ResearchAndMarkets.com
Wednesday, 12 August 2020, 18:30:00
DUBLIN–(BUSINESS WIRE)–The “Spinal Fusion (Orthopedic Devices) – Global Market Analysis and Forecast Model (COVID-19 market impact)” report has been added to ResearchAndMarkets.com’s offering. This market model discusses in detail the impact of COVID-19 on Spinal Fusion market for the year 2020 and beyond. Companies Mentioned Medtronic plc NuVasive Inc. DePuy Synthes Inc. Globus Medical Inc. Stryker Corp. Zimmer Biomet Holdings Inc. Lumbar fusions are the most common spinal fusion procedures
— Business Wire
Global Cannula Market (2020 to 2025) – Featuring CONMED, Edwards Lifesciences & Medtronic Among Others – ResearchAndMarkets.com
Wednesday, 12 August 2020, 10:59:00
DUBLIN–(BUSINESS WIRE)–The “Cannula Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025” report has been added to ResearchAndMarkets.com’s offering. The global cannula market grew at a CAGR of around 6% during 2014-2019. A cannula is a small hollow tube with a sharp and retractable inner core that is inserted into a vein, artery or body cavity to administer medication and draw off fluids. Several types of cannula are available for performing different proce
— Business Wire
Medtronic to invest Rs 1,200 crore to expand Hyderabad R&D center
Wednesday, 12 August 2020, 07:54:00
Rama Rao briefed the Medtronic leadership team on various initiatives taken by Telangana government to promote the medical devices sector
— Deccan Chronicle
Medtronic to invest Rs 1,200 cr to expand Hyd R&D centre – Times of India
Wednesday, 12 August 2020, 00:41:00
India Business News: Hyderabad: In a move that’s sure to boost Telangana’s ambitions to emerge as a global medical devices hub, the $30.
— The India Times